Insurances.net
Insurance plans
Finance
Biz
Insurances
insurances.net
»
Cancer Insurance
» Aarkstore Enterprise-molecular Diagnostics In Cancer Testing
Auto Insurance
Life Insurance
Health Insurance
Family Insurance
Travel Insurance
Mortgage Insurance
Accident Insurance
Buying Insurance
Housing Insurance
Personal Insurance
Medical Insurance
Property Insurance
Pregnant Insurance
Internet Insurance
Mobile Insurance
Pet Insurance
Employee Insurance
Dental Insurance
Liability Insurance
Baby Insurance
Children Insurance
Boat Insurance
Cancer Insurance
Insurance Quotes
Others
]
Aarkstore Enterprise-molecular Diagnostics In Cancer Testing
Table of Contents :
Table of Contents :
1. Overview 6
1.1 Statement of Report 6
1.2 About This Report 6
1.3 Scope of the Report 7
1.4 Objectives 7
1.5 Methodology 8
1.6 Executive Summary 9
2. Introduction to Molecular Diagnostics 13
2.1 Opening Up of Opportunities in Molecular Diagnostics 13
2.2 Impact of the Human Genome Project on Molecular Diagnostics 15
2.3 Considerations for Molecular and Clinical Diagnostics 16
2.4 Molecular Diagnostics in the Post-Genomic Era 19
2.5 Advances in Molecular Diagnostics Technologies 20
2.6 Oligonucleotide Array Platforms 21
2.7 Emerging Cancer Personalized Medicine Market 22
2.8 Companion Tests for Drug Development 24
3. Cancer Diagnostics Molecular Testing Market 27
3.1 Market Description 30
3.1.1 Market Overview 30
3.1.2 Tumor Markers 31
3.1.3 Molecular Diagnostic Markers 39
3.1.4 Competitive Landscape 40
3.1.5 Sales and Marketing Strategies for Cancer Tests 42
3.1.5.1 North American Market 44
3.1.5.2 International Markets 45
3.1.5.3 Europe 45
3.1.5.4 Asia/Pacific 46
4. Molecular Diagnostic Tests for Cancer 47
4.1 Cancer Diagnostic Tests 47
4.1.1 Use of Genomics to Understand Cancer 48
4.1.2 Molecular Diagnostic Tools Solutions 50
4.1.3 Technology of Gene Expression Analysis 51
4.1.3.1 Amplify and Detect Diminished Amounts of RNA Consistently 51
4.1.3.2 Analyze Hundreds of Genes 52
4.1.3.3 Employ Advanced Information Technology 52
4.2 Breast Cancer 53
4.2.1 Cancer Prognostic Assays 54
4.2.1.1 Oncotype DX 56
4.2.2 Single Gene Reporting (ER, PR, HER2) 57
4.2.2.1 Node Positive (N+) 57
4.2.2.2 Aromatase Inhibitors 57
4.2.3 Product Development 58
4.2.3.1 Product Development Opportunities in Breast Cancer 58
4.2.4 InterGenetics, Incorporated 58
4.2.5 HER-2 59
4.2.6 BioTheronostics (AviaraDx) 62
4.2.7 Agendia B.V. 63
4.2.8 Exagen 65
4.2.9 Applied Genomics 65
For more information please contact :
http://www.aarkstore.com/reports/Molecular-Diagnostics-in-Cancer-Testing-36109.html
http://blogs.aarkstore.com/
From:Aarkstore Enterprise
Contact: Neel
Email: press@aarkstore.com
http://www.aarkstore.com
by: Aarkstore Enterprise
POST COMMENT
$600,000 Settlement After Doctor Did Not Inform Patient Tests Showed Chance Of Prostate Cancer
$2.5 Million Settlement After Doctors Delay Diagnosis Of Patient's Prostate Cancer
$2.5 Million Claim For Colon Cancer Death Of 27 Year Old After Physician Dismissed Her Complaints
$12,000,000 Jury Verdict For Patient After Physicians Misdiagnosed Her Breast Cancer
Chemical Peels One Of The Best Clinical Skin Rejuvenation Treatments
Recognizing Bladder Cancer Causes
Early Diagnosis Of Breast Cancer Leads To Successful Treatment
Find The Easiest Way To Get Parcels Delivered To Edinburgh
Various Rheumatoid Arthritis Treatments
In Addition To Professional Treatments, Sanitation Key To Commercial Pest Control
Dish Latino Delivers You With The Eye Grabbing Content
Harmful Chemicals Of Bathroom Items Cause Skin Cancers
Hemorrhoid Treatments - Which Of Them Work Most Effectively
Write post
print
www.insurances.net
guest:
register
|
login
|
search
IP(18.190.239.189) Mato Grosso do Sul / Campo Grande Processed in 0.008907 second(s), 5 queries , Gzip enabled debug code: 115 , 2616, 301,
Aarkstore Enterprise-molecular Diagnostics In Cancer Testing Campo Grande